EBITDA Summary of Amgen Inc.

Amgen Inc.'s latest annual EBITDA in 2023 was 12.23 Billion USD , up 69.12% from previous year.
Amgen Inc.'s latest quarterly EBITDA in 2024 Q3 was 2.04 Billion USD , up 59.18% from previous quarter.
Amgen Inc. reported an annual EBITDA of 12.09 Billion USD in 2022, down -6.92% from previous year.
Amgen Inc. reported an annual EBITDA of 12.54 Billion USD in 2021, up 0.09% from previous year.
Amgen Inc. reported a quarterly EBITDA of 3.25 Billion USD for 2024 Q2, up 38.88% from previous quarter.
Amgen Inc. reported a quarterly EBITDA of 2.04 Billion USD for 2024 Q3, up 59.18% from previous quarter.

Annual EBITDA Chart of Amgen Inc. (2023 - 1990)

Historical Annual EBITDA of Amgen Inc. (2023 - 1990)

Year	EBITDA	EBITDA Growth
2023	12.23 Billion USD	69.12%
2022	12.09 Billion USD	-6.92%
2021	12.54 Billion USD	0.09%
2020	12.92 Billion USD	-9.9%
2019	12.63 Billion USD	-4.66%
2018	12.88 Billion USD	0.33%
2017	12.8 Billion USD	4.59%
2016	11.93 Billion USD	14.88%
2015	11.13 Billion USD	36.31%
2014	8.74 Billion USD	5.87%
2013	7.39 Billion USD	-1.09%
2012	6.35 Billion USD	25.76%
2011	5.05 Billion USD	-18.68%
2010	6.67 Billion USD	2.29%
2009	6.58 Billion USD	-8.86%
2008	6.63 Billion USD	-8.66%
2007	5.98 Billion USD	0.47%
2006	7.26 Billion USD	26.61%
2005	5.68 Billion USD	10.56%
2004	4.16 Billion USD	38.11%
2003	3.77 Billion USD	-70.17%
2002	2.65 Billion USD	619.75%
2001	1.79 Billion USD	24.66%
2000	1.57 Billion USD	5.27%
1999	1.5 Billion USD	16.36%
1998	1.26 Billion USD	3.02%
1997	1.04 Billion USD	15.44%
1996	1.01 Billion USD	21.07%
1995	845 Million USD	-8.62%
1994	773 Million USD	57.11%
1993	601.9 Million USD	18.84%
1992	531.7 Million USD	328.07%
1991	144.9 Million USD	110.61%
1990	68.8 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	2.33 Billion USD	16.8%
2024 Q2	3.25 Billion USD	38.88%
2024 Q3	2.04 Billion USD	59.18%
2023 Q1	3.98 Billion USD	84.23%
2023 Q4	3.05 Billion USD	12.82%
2023 Q3	2.7 Billion USD	14.37%
2023 Q2	2.36 Billion USD	-40.63%
2023 FY	- USD	69.12%
2022 Q1	1.97 Billion USD	-20.11%
2022 Q2	1.85 Billion USD	-5.63%
2022 Q4	2.16 Billion USD	-21.63%
2022 FY	- USD	-6.92%
2022 Q3	2.76 Billion USD	48.47%
2021 Q4	2.46 Billion USD	0.61%
2021 FY	- USD	0.09%
2021 Q1	2.14 Billion USD	-2.41%
2021 Q2	2.34 Billion USD	9.43%
2021 Q3	2.45 Billion USD	4.56%
2020 Q2	2.32 Billion USD	-1.69%
2020 Q3	2.5 Billion USD	7.82%
2020 Q4	2.19 Billion USD	-12.48%
2020 Q1	2.36 Billion USD	3.59%
2020 FY	- USD	-9.9%
2019 Q2	2.89 Billion USD	9.0%
2019 FY	- USD	-4.66%
2019 Q4	2.28 Billion USD	-11.81%
2019 Q3	2.59 Billion USD	-10.57%
2019 Q1	2.65 Billion USD	4.73%
2018 Q3	2.44 Billion USD	-18.2%
2018 FY	- USD	0.33%
2018 Q1	2.95 Billion USD	16.14%
2018 Q4	2.53 Billion USD	3.59%
2018 Q2	2.99 Billion USD	1.25%
2017 Q4	2.54 Billion USD	-5.91%
2017 FY	- USD	4.59%
2017 Q1	2.78 Billion USD	6.7%
2017 Q2	2.86 Billion USD	2.76%
2017 Q3	2.7 Billion USD	-5.48%
2016 Q1	2.55 Billion USD	16.16%
2016 FY	- USD	14.88%
2016 Q4	2.61 Billion USD	-4.81%
2016 Q3	2.74 Billion USD	8.98%
2016 Q2	2.51 Billion USD	-1.37%
2015 Q2	2.27 Billion USD	6.86%
2015 FY	- USD	36.31%
2015 Q1	2.12 Billion USD	37.56%
2015 Q3	2.47 Billion USD	8.8%
2015 Q4	2.19 Billion USD	-11.2%
2014 Q4	1.54 Billion USD	-3.67%
2014 Q1	1.46 Billion USD	14.75%
2014 FY	- USD	5.87%
2014 Q3	1.6 Billion USD	-21.27%
2014 Q2	2.04 Billion USD	39.44%
2013 FY	- USD	-1.09%
2013 Q4	1.27 Billion USD	-27.56%
2013 Q2	1.64 Billion USD	2.49%
2013 Q1	1.6 Billion USD	24.79%
2013 Q3	1.76 Billion USD	6.93%
2012 Q1	1.67 Billion USD	11.15%
2012 Q3	1.6 Billion USD	-9.97%
2012 FY	- USD	25.76%
2012 Q4	1.28 Billion USD	-19.96%
2012 Q2	1.78 Billion USD	6.63%
2011 Q3	686 Million USD	-51.17%
2011 Q4	1.5 Billion USD	119.68%
2011 Q1	1.51 Billion USD	6.54%
2011 FY	- USD	-18.68%
2011 Q2	1.4 Billion USD	-7.26%
2010 Q4	1.42 Billion USD	-14.23%
2010 Q2	1.68 Billion USD	2.75%
2010 Q3	1.65 Billion USD	-1.54%
2010 FY	- USD	2.29%
2010 Q1	1.63 Billion USD	11.19%
2009 Q3	1.75 Billion USD	10.95%
2009 Q1	1.59 Billion USD	7.61%
2009 FY	- USD	-8.86%
2009 Q2	1.58 Billion USD	-1.13%
2009 Q4	1.47 Billion USD	-15.92%
2008 FY	- USD	-8.66%
2008 Q3	1.76 Billion USD	2.03%
2008 Q4	1.48 Billion USD	-15.77%
2008 Q1	1.69 Billion USD	-3.54%
2008 Q2	1.72 Billion USD	2.19%
2007 FY	- USD	0.47%
2007 Q1	1.64 Billion USD	-35.53%
2007 Q2	1.7 Billion USD	3.47%
2007 Q4	1.75 Billion USD	-20.35%
2007 Q3	2.2 Billion USD	29.39%
2006 Q3	1.6 Billion USD	-39.08%
2006 Q1	1.36 Billion USD	3.34%
2006 FY	- USD	26.61%
2006 Q4	2.55 Billion USD	58.48%
2006 Q2	2.64 Billion USD	93.76%
2005 FY	- USD	10.56%
2005 Q3	1.5 Billion USD	-3.66%
2005 Q2	1.55 Billion USD	14.8%
2005 Q1	1.35 Billion USD	-18.49%
2005 Q4	1.31 Billion USD	-12.18%
2004 Q2	1.18 Billion USD	7.34%
2004 Q4	1.66 Billion USD	35.02%
2004 FY	- USD	38.11%
2004 Q3	1.23 Billion USD	4.08%
2004 Q1	1.1 Billion USD	-9.48%
2003 Q2	817.1 Million USD	4.88%
2003 Q4	932 Million USD	31.95%
2003 Q1	662.2 Million USD	-89.8%
2003 Q3	1.02 Billion USD	5.97%
2003 FY	- USD	-70.17%
2002 Q1	518.1 Million USD	10.95%
2002 Q4	7.9 Billion USD	131.32%
2002 FY	- USD	619.75%
2002 Q3	689.4 Million USD	541.67%
2002 Q2	564.8 Million USD	22.72%
2001 Q3	522.9 Million USD	0.37%
2001 Q4	280.1 Million USD	-13.25%
2001 Q2	517.7 Million USD	11.2%
2001 FY	- USD	24.66%
2001 Q1	476.4 Million USD	16.38%
2000 Q4	351.1 Million USD	10.48%
2000 FY	- USD	5.27%
2000 Q3	440.1 Million USD	-12.25%
2000 Q2	411.3 Million USD	5.18%
2000 Q1	419.7 Million USD	2.6%
1999 Q1	346.4 Million USD	-1.35%
1999 Q3	395 Million USD	-5.35%
1999 FY	- USD	16.36%
1999 Q4	378.8 Million USD	8.8%
1999 Q2	381.6 Million USD	10.72%
1998 Q3	328.3 Million USD	2.04%
1998 FY	- USD	3.02%
1998 Q4	333.6 Million USD	2.97%
1998 Q1	280.9 Million USD	16.48%
1998 Q2	319.4 Million USD	13.29%
1997 Q4	244.2 Million USD	-41.69%
1997 Q3	247.9 Million USD	40.6%
1997 Q2	287.7 Million USD	8.02%
1997 Q1	267.6 Million USD	2.86%
1997 FY	- USD	15.44%
1996 Q2	264.8 Million USD	31.1%
1996 Q4	254.9 Million USD	-0.86%
1996 FY	- USD	21.07%
1996 Q1	222.3 Million USD	1.62%
1996 Q3	259.4 Million USD	-10.52%
1995 Q4	220.6 Million USD	-7.61%
1995 FY	- USD	-8.62%
1995 Q2	217.6 Million USD	20.63%
1995 Q1	176.8 Million USD	-47.02%
1995 Q3	230 Million USD	8.87%
1994 Q1	169 Million USD	20.74%
1994 FY	- USD	57.11%
1994 Q4	209.7 Million USD	60.6%
1994 Q3	202.5 Million USD	4.22%
1994 Q2	192.1 Million USD	13.93%
1993 Q2	152.4 Million USD	-0.62%
1993 Q3	162.6 Million USD	23.56%
1993 Q4	150.1 Million USD	-13.22%
1993 FY	- USD	18.84%
1993 Q1	136.9 Million USD	-33.16%
1992 Q3	128.2 Million USD	11.34%
1992 Q4	204.4 Million USD	89.62%
1992 Q1	90.8 Million USD	4.21%
1992 FY	- USD	328.07%
1992 Q2	108.4 Million USD	15.78%
1991 Q1	57.2 Million USD	262.15%
1991 Q3	70.2 Million USD	175.69%
1991 Q4	86.3 Million USD	31.94%
1991 FY	- USD	190.67%
1991 Q2	-68.8 Million USD	-248.05%
1990 FY	- USD	0.0%
1990 Q1	14.4 Million USD	17.19%
1990 Q2	17.2 Million USD	-13.33%
1990 Q4	-25 Million USD	-349.61%
1990 Q3	19.4 Million USD	-2.31%
1989 Q2	4.3 Million USD	106.85%
1989 Q1	-62.8 Million USD	-394.84%
1989 Q4	14.7 Million USD	141.51%
1989 Q3	7.6 Million USD	23.26%

Peer EBITDA Comparison of Amgen Inc.

Name	EBITDA	EBITDA Difference
AstraZeneca PLC	12.97 Billion USD	5.718%
Biogen Inc.	2.37 Billion USD	-414.724%
Gilead Sciences, Inc.	10.49 Billion USD	-16.568%
MIRA Pharmaceuticals, Inc.	- USD	-Infinity%
Scilex Holding Company	-109.1 Million USD	11314.071%
Scilex Holding Company	-109.1 Million USD	11314.071%

Global Stocks Search

Amgen Inc. (AMGN)

EBITDA Summary of Amgen Inc.

Annual EBITDA Chart of Amgen Inc. (2023 - 1990)

Historical Annual EBITDA of Amgen Inc. (2023 - 1990)

Peer EBITDA Comparison of Amgen Inc.